POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding POINT Biopharma Global Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 115 | 130 | +15 |
| Shares | 62.6M | 63.0M | +398.1K (+0.6%) |
| Value | $455.0M | $570.6M | +$115.6M (+25.4%) |
New holders (31)
Institutions that held POINT Biopharma Global Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (16)
Institutions that held POINT Biopharma Global Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 290,618 | $2.11M |
| Sectoral Asset Management Inc | 182,668 | $1.33M |
| Affinity Asset Advisors, LLC | 149,586 | $1.09M |
| Corton Capital Inc. | 35,665 | $259.3K |
| HRT Financial LP | 34,235 | $248.0K |
| Atom Investors LP | 31,821 | $231.3K |
| Delphia (USA) Inc. | 28,905 | $210.1K |
| XTX Topco Ltd | 25,128 | $182.7K |
| Boothbay Fund Management, LLC | 24,323 | $176.8K |
| Fox Run Management, L.L.C. | 20,744 | $150.8K |
| Ergoteles LLC | 19,400 | $141.0K |
| Verition Fund Management LLC | 18,883 | $137.3K |
| Raymond James Financial Services Advisors, Inc. | 13,500 | $98.1K |
| Amundi | 5,829 | $40.7K |
| Tucker Asset Management LLC | 500 | $3.63K |
| The PNC Financial Services Group, Inc. | 200 | $1.45K |